Protein Acetylation Going Viral: Implications in Antiviral Immunity and Viral Infection.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
25 Sep 2022
Historique:
received: 26 08 2022
revised: 10 09 2022
accepted: 21 09 2022
entrez: 14 10 2022
pubmed: 15 10 2022
medline: 18 10 2022
Statut: epublish

Résumé

During viral infection, both host and viral proteins undergo post-translational modifications (PTMs), including phosphorylation, ubiquitination, methylation, and acetylation, which play critical roles in viral replication, pathogenesis, and host antiviral responses. Protein acetylation is one of the most important PTMs and is catalyzed by a series of acetyltransferases that divert acetyl groups from acetylated molecules to specific amino acid residues of substrates, affecting chromatin structure, transcription, and signal transduction, thereby participating in the cell cycle as well as in metabolic and other cellular processes. Acetylation of host and viral proteins has emerging roles in the processes of virus adsorption, invasion, synthesis, assembly, and release as well as in host antiviral responses. Methods to study protein acetylation have been gradually optimized in recent decades, providing new opportunities to investigate acetylation during viral infection. This review summarizes the classification of protein acetylation and the standard methods used to map this modification, with an emphasis on viral and host protein acetylation during viral infection.

Identifiants

pubmed: 36232610
pii: ijms231911308
doi: 10.3390/ijms231911308
pmc: PMC9570087
pii:
doi:

Substances chimiques

Amino Acids 0
Antiviral Agents 0
Chromatin 0
Viral Proteins 0
Acetyltransferases EC 2.3.1.-

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Natural Science Foundation of China
ID : 81971917 and 32170142
Organisme : Jiangsu Natural Science Foundation
ID : BK20211310

Références

J Cell Biol. 1987 Feb;104(2):303-9
pubmed: 3543025
J Gen Virol. 2017 Mar;98(3):322-337
pubmed: 27959772
Vet Res. 2020 Feb 24;51(1):20
pubmed: 32093780
J Clin Invest. 2012 Feb;122(2):529-37
pubmed: 22251702
Mol Cell. 2010 Jun 11;38(5):722-32
pubmed: 20542004
Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):19975-9
pubmed: 19906987
Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54
pubmed: 22814378
Expert Rev Proteomics. 2019 Feb;16(2):139-159
pubmed: 30580641
Nat Rev Drug Discov. 2012 Apr 13;11(5):384-400
pubmed: 22498752
EBioMedicine. 2016 Jul;9:195-206
pubmed: 27372014
J Biomol NMR. 2012 Nov;54(3):217-36
pubmed: 23011410
Nat Immunol. 2016 Jul;17(7):806-15
pubmed: 27240213
J Biol Chem. 2011 Mar 18;286(11):9280-6
pubmed: 21220424
Cell. 2007 Oct 5;131(1):93-105
pubmed: 17923090
Genome Biol. 2002;3(5):reviews0006
pubmed: 12049668
PLoS Genet. 2011 Jul;7(7):e1002169
pubmed: 21750686
Int J Biol Sci. 2011;7(5):575-87
pubmed: 21614150
FEBS Lett. 2011 Jan 3;585(1):128-32
pubmed: 21094644
Proc Natl Acad Sci U S A. 2009 May 19;106(20):8157-62
pubmed: 19420222
Nucleic Acids Res. 2004 Feb 11;32(3):959-76
pubmed: 14960713
Biochem J. 2008 Oct 15;415(2):325-31
pubmed: 18570629
J Biol Chem. 2002 Jun 21;277(25):22304-13
pubmed: 11940575
EMBO J. 2002 Dec 2;21(23):6539-48
pubmed: 12456660
Biochem Biophys Res Commun. 2018 Oct 12;504(4):635-640
pubmed: 30205953
Mol Cell Proteomics. 2011 May;10(5):M110.004580
pubmed: 21383206
Retrovirology. 2010 Mar 12;7:18
pubmed: 20226045
Curr Opin Biotechnol. 2011 Feb;22(1):9-16
pubmed: 20926283
Future Med Chem. 2016 Nov;8(17):2017-2031
pubmed: 27739328
Cell Cycle. 2011 Nov 1;10(21):3701-5
pubmed: 22033337
Mol Cell Biol. 2009 Jul;29(13):3569-81
pubmed: 19398576
Virology. 2004 Feb 5;319(1):60-70
pubmed: 14967488
Epigenetics. 2013 Oct;8(10):1101-13
pubmed: 23949383
Cell Physiol Biochem. 2018;49(1):381-394
pubmed: 30138929
Cell Host Microbe. 2013 Nov 13;14(5):535-46
pubmed: 24237699
Viruses. 2021 Jul 20;13(7):
pubmed: 34372620
Biochim Biophys Acta Gene Regul Mech. 2017 Apr;1860(4):491-501
pubmed: 28242208
Trends Biochem Sci. 2012 Apr;37(4):152-61
pubmed: 22405572
Biochemistry. 2009 Oct 13;48(40):9582-9
pubmed: 19747004
Biochem J. 2005 Mar 15;386(Pt 3):433-43
pubmed: 15496142
Biochim Biophys Acta. 1999 Jul 13;1432(2):333-49
pubmed: 10407155
Nat Commun. 2017 Nov 2;8(1):1259
pubmed: 29097654
PLoS Genet. 2013;9(9):e1003805
pubmed: 24068969
Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10558-63
pubmed: 22691496
Nucleic Acids Res. 2021 Feb 26;49(4):2044-2064
pubmed: 33533922
J Virol. 2019 Feb 5;93(4):
pubmed: 30518648
Nat Rev Mol Cell Biol. 2019 Mar;20(3):156-174
pubmed: 30467427
PLoS One. 2011;6(9):e24713
pubmed: 21935442
PLoS Pathog. 2021 Jun 10;17(6):e1009616
pubmed: 34111220
Arch Virol. 2019 Feb;164(2):559-565
pubmed: 30374707
J Biol Chem. 2018 May 11;293(19):7126-7138
pubmed: 29555684
Trends Biochem Sci. 2007 May;32(5):210-6
pubmed: 17412595
Mol Cancer Res. 2007 Oct;5(10):981-9
pubmed: 17951399
Proc Natl Acad Sci U S A. 1974 Aug;71(8):2988-91
pubmed: 4528404
Cell Cycle. 2019 Sep;18(17):1995-2005
pubmed: 31291816
Mol Cell. 2020 Jul 16;79(2):304-319.e7
pubmed: 32679077
Cell Rep. 2015 Mar 3;10(8):1362-74
pubmed: 25732826
CRC Crit Rev Biochem. 1985;18(4):281-325
pubmed: 3902358
J Virol. 2019 Mar 21;93(7):
pubmed: 30651357
J Biol Chem. 2010 Dec 10;285(50):39329-38
pubmed: 20947501
Biochem Biophys Res Commun. 2021 Jun 11;557:273-279
pubmed: 33894414
J Biol Chem. 2001 Jul 27;276(30):28179-84
pubmed: 11384967
EMBO J. 1999 Nov 1;18(21):6106-18
pubmed: 10545121
Cell. 2007 Nov 16;131(4):633-6
pubmed: 18022353
J Virol. 2014 Oct;88(19):11229-39
pubmed: 25031336
J Mol Med (Berl). 2003 Sep;81(9):549-57
pubmed: 12920522
Int Rev Cell Mol Biol. 2015;316:267-305
pubmed: 25805127
Proc Natl Acad Sci U S A. 2020 Sep 1;117(35):21568-21575
pubmed: 32817552
J Biol Chem. 2015 Jan 16;290(3):1485-95
pubmed: 25429107
J Biomed Biotechnol. 2012;2012:452934
pubmed: 23093844
Science. 2005 Jan 14;307(5707):269-73
pubmed: 15653507
Proteomics. 2018 Jan;18(1):
pubmed: 29150924
Biochim Biophys Acta. 2016 Oct;1864(10):1372-401
pubmed: 27296530
EMBO J. 2016 Feb 15;35(4):429-42
pubmed: 26746851
J Biomed Biotechnol. 2011;2011:970382
pubmed: 21151618
EMBO J. 2005 Sep 7;24(17):3070-81
pubmed: 16096645
J Biol Chem. 2002 Dec 20;277(51):49417-21
pubmed: 12374802
J Biomed Biotechnol. 2011;2011:146493
pubmed: 21234400
PLoS Pathog. 2011 Aug;7(8):e1002184
pubmed: 21876670
Gastroenterology. 2006 Mar;130(3):823-37
pubmed: 16530522
Mol Cell Proteomics. 2010 May;9(5):928-39
pubmed: 20061308
J Pept Sci. 2010 Aug;16(8):414-23
pubmed: 20572211
FEBS J. 2022 Jan;289(1):231-245
pubmed: 34270849

Auteurs

Minfei Xue (M)

Department of Respiratory Medicine, Children's Hospital of Soochow University, Soochow University, Suzhou 215025, China.
Jiangsu Key Laboratory of Infection and Immunity, Institute of Biology and Medical Sciences, Soochow University, Suzhou 215123, China.

Tingting Feng (T)

Jiangsu Key Laboratory of Infection and Immunity, Institute of Biology and Medical Sciences, Soochow University, Suzhou 215123, China.

Zhiqiang Chen (Z)

Jiangsu Key Laboratory of Infection and Immunity, Institute of Biology and Medical Sciences, Soochow University, Suzhou 215123, China.

Yongdong Yan (Y)

Department of Respiratory Medicine, Children's Hospital of Soochow University, Soochow University, Suzhou 215025, China.

Zhengrong Chen (Z)

Department of Respiratory Medicine, Children's Hospital of Soochow University, Soochow University, Suzhou 215025, China.

Jianfeng Dai (J)

Jiangsu Key Laboratory of Infection and Immunity, Institute of Biology and Medical Sciences, Soochow University, Suzhou 215123, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH